title: [Not Available].
authors.affiliation: 1 Klinik für Urologie, Kantonsspital Winterthur.
authors.forename: Jan
authors.initials: J
authors.lastname: Brachlow
authors.affiliation: 2 Klinik für Onkologie, Kantonsspital Winterthur.
authors.forename: Martin
authors.initials: M
authors.lastname: Kälin
authors.affiliation: 1 Klinik für Urologie, Kantonsspital Winterthur.
authors.forename: Marco
authors.initials: M
authors.lastname: Randazzo
authors.affiliation: 1 Klinik für Urologie, Kantonsspital Winterthur.
authors.forename: Beat
authors.initials: B
authors.lastname: Förster
authors.affiliation: 1 Klinik für Urologie, Kantonsspital Winterthur.
authors.forename: Hubert
authors.initials: H
authors.lastname: John
mesh_terms: D003131:Combined Modality Therapy; D003430:Cross-Sectional Studies; D018450:Disease Progression; D055088:Early Detection of Cancer; D005858:Germany; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate
chemical_list: D017430:Prostate-Specific Antigen
keywords: PSA; PSA screening; PSA-Screening; Therapieoptionen; advanced prostate cancer; cancer de la prostate avancé; cancer de la prostate localisé; fortgeschrittenes Prostatakarzinom; localised prostate cancer; lokales Prostatakarzinom; options thérapeutiques; screening; therapy options